May 10, 2025

Investors

Investors

South Korea’s short-selling ban has ended; will global investors flock back?

SOUTH Korea’s US$1.7 trillion stock market is once again open to short selling, after the ban on the trading tactic used by hedge funds and banks around the world was lifted on Mar 31. The latest prohibition on short selling was introduced in November 2023 as authorities sought to address concerns about market fairness and

Read More
Investors

Investors’ attention turns to impact of US tariffs

Despite mixed cues from global markets amid concerns over upcoming US tariffs; Indian market extended the gains for the second consecutive week on the back of persistent buying from domestic as well as FIIs and appreciation in rupee against the dollar. BSE Sensex added 509.41 points or 0.66 percent to end at 77,414.92, and NSE

Read More
Investors

Japan stocks slump nearly 4% as fresh Trump tariffs due this week keep investors jittery – NBC4 Washington

This is CNBC’s live blog covering Asia-Pacific markets. Asia-Pacific markets plunged Monday ahead of U.S. President Donald Trump’s fresh round of tariffs expected later in the week. Japan’s benchmark Nikkei 225 started the day 3.9% lower while the broader Topix index lost 3.7%. Over in South Korea, the Kospi index fell 2.4% while the small-cap Kosdaq declined 2.32%.

Read More
Investors

Private-markets access for retail investors is mostly good – but with caveats

Investors should be cautious about factors such as the policing of funds’ marketing, disclosures and practices, as well as the advisory process [SINGAPORE] Allowing retail investors to allocate to private-market funds is surely a good thing. Higher returns are sorely needed for retirement portfolios. But it warrants caution as well. The devil is in the

Read More
Investors

FDA’s ‘key man’ Peter Marks is out. Biotech investors will now deal with the consequences

Robert F. Kennedy Jr. forcing Peter Marks out of the Food and Drug Administration has blown a hole in the agency’s leadership ranks and threatens to unmoor the oversight of drugs and vaccines from bedrock scientific principles.  For biotech investors, Marks’ ouster is a worst-case scenario realized — an FDA riven by dysfunction and uncertainty.

Read More
Investors

Warren Buffett Has Seen His Share of Market Downturns. His Message to Investors: Keep Your Cool.

The stock market has been rather turbulent through the first quarter of 2025, and with the uncertainty surrounding tariffs, interest rates, and recession fears, there’s no way to know when that will change. The S&P 500 benchmark index recently dipped into correction territory, and although it is now down by about 9% from recent highs,

Read More
Investors

Ride out the market turmoil? Not these investors

After the dot-com bubble burst in the early 2000s, Lars Staack decided to play it safe and invest his retirement savings in S&P 500 index funds, which are diversified and carry lower risk than owning individual stocks. It was a strategy that brought him peace of mind for more than two decades — until President

Read More
Investors

Eli Lilly Vs. Novo Nordisk: Which Is The Better Bargain For Investors (NYSE:NVO)

This article was written by Follow With over two decades of dedicated experience in investment, Allka Research has been a guiding force for individuals seeking lucrative opportunities. Its conservative approach sets it apart, consistently unearthing undervalued assets within the realms of ETFs, commodities, technology, and pharmaceutical companies.Allka Research’s journey in the investment landscape is marked

Read More
Investors

American Oncology: A Buy Rating For Bold Growth Investors (OTCMKTS:AONC)

This article was written by Follow Robert F. Abbott has been investing his family’s accounts since 1995, and in 2010 added options, mainly covered calls and collars with long stocks. He is a freelance writer, and his projects include a website that provides information for new and intermediate-level mutual fund investors. A resident of Airdrie,

Read More
Investors

Investors feared to have lost millions in 300-home new build development promoted by ex-Premier League star Robbie Fowler

Investors feared to have lost millions of pounds in a property scheme promoted by former Premier League striker Robbie Fowler have told of their anger. Stunning images were released during a media blitz showcasing the ambitious scheme to build over 300 new apartments on the edge of Liverpool city centre. Mr Fowler, known as ‘God’

Read More
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent. View more
Accept
Decline